Stockscreener 앱 받기
20.82
1.61%
0.33
시간 외 거래:
20.89
0.07
+0.34%
전일 마감가:
$20.49
열려 있는:
$20.35
하루 거래량:
55,872
Relative Volume:
0.52
시가총액:
$696.08M
수익:
-
순이익/손실:
-
주가수익비율:
-3.9362
EPS:
-5.2894
순현금흐름:
-
1주 성능:
+4.00%
1개월 성능:
-1.70%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$20.29
$21.05
1주일 범위
$19.68
$21.91
52주 변동 폭
$17.06
$30.56
Spyglass Pharma Inc Stock (SGP) Company Profile
명칭
Spyglass Pharma Inc
전화
949-284-6904
주소
27081 ALISO CREEK ROAD, ALISO VIEJO
Compare SGP vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGP
Spyglass Pharma Inc
|
20.82 | 685.05M | 0 | 0 | 0 | -5.2894 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Spyglass Pharma Inc Stock (SGP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-10 | 개시 | H.C. Wainwright | Buy |
| 2026-03-03 | 개시 | Citigroup | Buy |
| 2026-03-03 | 개시 | Jefferies | Buy |
| 2026-03-03 | 개시 | Leerink Partners | Outperform |
| 2026-03-03 | 개시 | Stifel | Buy |
Spyglass Pharma Inc 주식(SGP)의 최신 뉴스
SGP|SpyGlass Pharma Ord shs (Proposed)|Price:20.490|Chg%:-0.390 - TradingKey
Spyglass Pharma (NASDAQ:SGP) Shares Gap UpStill a Buy? - MarketBeat
SpyGlass Pharma, Inc. Revenue Breakdown – NASDAQ:SGP - TradingView
SpyGlass Pharma (SGP) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Top Spyglass Pharma (SGP) Competitors 2026 - MarketBeat
SpyGlass Pharma (SGP) Drops 4.77% as Key Support Levels Are TestedFade Trade - dars.gov.et
SpyGlass Pharma (SGP) Rallies 2.67%, Tests Key Resistance LevelDynamic Hedging - dars.gov.et
Spyglass Pharma (SGP) Insider Trading Activity 2026 $SGP - MarketBeat
SpyGlass Pharma Inc. (SGP) Q1 2026 Earnings: Wider-Than-Expected Loss Triggers Double-Digit Selloff - dars.gov.et
SpyGlass Pharma Q1 2026 Earnings: EPS Miss on Pre‑Revenue Status Pressures StockLow Growth Earnings - DonanımHaber
SGP Q1 2026 Earnings: EPS Misses Estimates, Stock Edges HigherLong-Term Guidance - dars.gov.et
SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to Russell 2000 Index - marketscreener.com
SpyGlass Pharma, Inc.(NasdaqGS:SGP) added to Russell Microcap Value Benchmark Index - marketscreener.com
SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to Russell 2000 Value Benchmark - marketscreener.com
SpyGlass Pharma (SGP) Registration Filing Summary - Quartr
SpyGlass Pharma, Inc.(NasdaqGS:SGP) added to Russell Microcap Growth Benchmark Index - marketscreener.com
SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to Russell 2000 Growth Benchmark - marketscreener.com
SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to Russell 3000E Growth Benchmark - marketscreener.com
SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to Russell Microcap Index - marketscreener.com
SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to Russell Small Cap Completeness Index - marketscreener.com
SGP Forecast — Price Target — Prediction for 2027 - TradingView
Transcript : SpyGlass Pharma, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-10-2026 10 - marketscreener.com
SpyGlass Pharma, Inc. Actuals & Estimates (NASDAQ:SGP) - TradingView
Price to sales forward of SpyGlass Pharma, Inc. – NASDAQ:SGP - TradingView
Enterprise value to revenue forward of SpyGlass Pharma, Inc. – NASDAQ:SGP - TradingView
Price to book forward of SpyGlass Pharma, Inc. – NASDAQ:SGP - TradingView
Price to earnings forward of SpyGlass Pharma, Inc. – NASDAQ:SGP - TradingView
Enterprise value to EBIT forward of SpyGlass Pharma, Inc. – NASDAQ:SGP - TradingView
Spyglass Pharma (SGP) Short Interest & Short Float | Updated Jun 2026 $SGP - MarketBeat
SpyGlass Pharma Inc. Q1 2026 Earnings: Wider-Than-Expected Loss Fails to Dampen Investor OptimismRevenue Miss Report - dars.gov.et
SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to S&P Global BMI Index - marketscreener.com
SpyGlass Pharma Inc. (SGP) Rallies 2.75% as Stock Tests Key Resistance LevelsSell Signal Alerts - DonanımHaber
SpyGlass Pharma (SGP) Gains 2.75% as Shares Test Key Resistance LevelsMA Crossover - dars.gov.et
SpyGlass Pharma Ord shs (Proposed) (SGP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SpyGlass Taps Shannon Treviño as General Counsel - Orange County Business Journal
SpyGlass Pharma appoints Shannon Treviño as general counsel to support Phase 3 trials and commercialization plans. - Pluang
SpyGlass Pharma appoints Shannon Treviño as general counsel By Investing.com - Investing.com Nigeria
SpyGlass Pharma, Inc. Announces Appointment of Shannon Treviño to General Counsel - marketscreener.com
SpyGlass Pharma appoints Shannon Treviño as general counsel - Investing.com
SpyGlass Pharma Appoints Shannon Treviño as General Counsel - GlobeNewswire
SpyGlass Pharma Inc. Q1 2026 Earnings: Wider-than-Expected Loss Highlights Pre-Revenue ChallengesAnnual Report - dars.gov.et
Spyglass Pharma (SGP) Earnings Date and Reports 2026 $SGP - MarketBeat
Spyglass Pharma (SGP) Stock Chart and Price History 2026 $SGP - MarketBeat
SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing - VisionMonday.com
SpyGlass Pharma appoints Mike Pinder as VP of marketing By Investing.com - Investing.com South Africa
SpyGlass Pharma appoints Mike Pinder as VP of marketing - Investing.com
SpyGlass Pharma (SGP) Slides 2.29% as Stock Approaches Critical Support at $17.0Liquidity Sweep - dars.gov.et
SGP Q1 2026 Earnings: Wider-than-Expected Loss Highlights Pre-Revenue ChallengesCapex Guidance - dars.gov.et
SGPSpyGlass Pharma Inc Stock Price and Quote - Finviz
SpyGlass Pharma to Participate in Upcoming Investor Conferences - Sahm
SpyGlass Pharma: New add-on CPT code supports BIM-IOL System - Eyes On Eyecare
Spyglass Pharma Inc (SGP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.97%
0.83%
자본화:
|
볼륨(24시간):